Rua Bioscience has appointed Paul Naske as Chief Executive Officer, effective 1 March 2023.

Paul has held roles as Chief Operations Officer and Chief Commercial Officer, and has demonstrated visible leadership and fostered a patient-focused approach aligned with the company's values.

Interim Managing Director, Anna Stove, will return to the Board as Chair in succession to Trevor Burt, who retires due to ill health.

Anna expressed her gratitude to Trevor for his invaluable corporate executive and governance experience.

See more